Blog|Videos|January 9, 2024
Importance of a Hybrid Approach to Manufacturing and Sourcing
Author(s)Actylis
Bradley Grobler, Vice President of Sales, Pharma & Biopharma Europe, describes how Actylis meets global demands for (bio)pharmaceutical development and manufacturing programs during CPhI 2023.
Learn more:
- A unique hybrid model of global manufacturing and sourcing
- R&D services and custom manufacturing for pharmaceutical and biopharmaceutical companies combining the collective expertise of more than 75 years
- Flexible manufacturing capacity and scalability offered by combining in-house capabilities and toll partners’ scale
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
